Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug R&D for prevalent chronic diseases.
Table of Contents
|2 Person-Centered Drug Research and Development||5-14|
|3 New Technologies to Enable Research in Prevalent Chronic Disease||15-28|
|4 Investment and Incentives||29-38|
|5 Learning from Success||39-50|
|6 Lessons Learned for the Future||51-62|
|7 Reflections and Final Thoughts||63-72|
|Appendix A: Workshop Agenda||73-82|
|Appendix B: Biographical Sketches of Workshop Speakers||83-94|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Innovation in Drug Research and Development for Prevalent Chronic Diseases: Proceedings of a Workshop...